AstraZeneca Pharma India has informed that the Company has signed a Letter of Intent (‘LOI’) with Strand Life Sciences (‘Strand’), a genomics research and diagnostics company and a subsidiary of Reliance Industries, to explore opportunities to collaborate in healthcare in India. The Company and Strand are not related parties, and the execution of the LOI does not constitute a related party transaction. Communication in relation to the above is disseminated through the LinkedIn handle of the Company and is accessible at AstraZeneca India. The above information is also being made available on the website of the Company at www.astrazeneca.com/india.
The above information is a part of company’s filings submitted to BSE.